AU2014364539B2 - Biomarkers of de novo lipogenesis and methods using the same" (i.e. change Biomakers to Biomarkers) - Google Patents

Biomarkers of de novo lipogenesis and methods using the same" (i.e. change Biomakers to Biomarkers) Download PDF

Info

Publication number
AU2014364539B2
AU2014364539B2 AU2014364539A AU2014364539A AU2014364539B2 AU 2014364539 B2 AU2014364539 B2 AU 2014364539B2 AU 2014364539 A AU2014364539 A AU 2014364539A AU 2014364539 A AU2014364539 A AU 2014364539A AU 2014364539 B2 AU2014364539 B2 AU 2014364539B2
Authority
AU
Australia
Prior art keywords
dnl
level
biomarkers
acid
index
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2014364539A
Other languages
English (en)
Other versions
AU2014364539A1 (en
Inventor
Steven M. Watkins
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Metabolon Inc
Original Assignee
Metabolon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Metabolon Inc filed Critical Metabolon Inc
Publication of AU2014364539A1 publication Critical patent/AU2014364539A1/en
Application granted granted Critical
Publication of AU2014364539B2 publication Critical patent/AU2014364539B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/70—Mechanisms involved in disease identification
    • G01N2800/7057—(Intracellular) signaling and trafficking pathways
    • G01N2800/7066—Metabolic pathways
    • G01N2800/7085—Lipogenesis or lipolysis, e.g. fatty acid metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
AU2014364539A 2013-12-20 2014-12-18 Biomarkers of de novo lipogenesis and methods using the same" (i.e. change Biomakers to Biomarkers) Active AU2014364539B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361918866P 2013-12-20 2013-12-20
US61/918,866 2013-12-20
US201461934033P 2014-01-31 2014-01-31
US61/934,033 2014-01-31
PCT/US2014/071035 WO2015095451A1 (en) 2013-12-20 2014-12-18 Biomakers of de novo lipogenesis and methods using the same

Publications (2)

Publication Number Publication Date
AU2014364539A1 AU2014364539A1 (en) 2016-06-16
AU2014364539B2 true AU2014364539B2 (en) 2019-08-01

Family

ID=53403674

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2014364539A Active AU2014364539B2 (en) 2013-12-20 2014-12-18 Biomarkers of de novo lipogenesis and methods using the same" (i.e. change Biomakers to Biomarkers)

Country Status (9)

Country Link
US (1) US20160356798A1 (enExample)
EP (1) EP3082833B1 (enExample)
JP (1) JP6557235B2 (enExample)
AU (1) AU2014364539B2 (enExample)
CA (1) CA2933571A1 (enExample)
ES (1) ES2708807T3 (enExample)
MX (1) MX2016008045A (enExample)
SG (1) SG11201604702YA (enExample)
WO (1) WO2015095451A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105400732A (zh) * 2015-11-19 2016-03-16 南京理工大学 一种酒精性脂肪肝斑马鱼模型的构建方法
JP6992057B2 (ja) 2016-06-10 2022-01-13 クラリティ コスメティックス インコーポレイテッド 非面皰形成性の毛髪および頭皮ケア製剤ならびにその使用方法
GB201614455D0 (en) 2016-08-24 2016-10-05 Univ Oxford Innovation Ltd Biomarkers
US11709169B2 (en) * 2017-02-07 2023-07-25 National Jewish Health Lipid abnormalities and association with atopic allergic diseases
EP3602605A4 (en) * 2017-03-31 2020-12-30 Metabolon, Inc. FULL AND QUANTITATIVE ANALYSIS OF LIPIDS AND TOCOPHEROLS
US11642300B2 (en) 2019-05-15 2023-05-09 Johnson & Johnson Consumer Inc. Method of selecting skin treatment regimens, ingredients and compositions
US20220142560A1 (en) 2020-11-06 2022-05-12 Johnson & Johnson Consumer Inc. Microbiome and metobolome clusters to evaluate skin health

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1438420B1 (en) * 2001-09-24 2009-09-16 Lipomics Technologies, Inc. Methods of using quantitative lipid metabolome data
JP4682980B2 (ja) * 2004-04-23 2011-05-11 味の素株式会社 非アルコール性脂肪肝炎鑑別方法
US8119358B2 (en) * 2005-10-11 2012-02-21 Tethys Bioscience, Inc. Diabetes-related biomarkers and methods of use thereof
CN102317786A (zh) * 2007-04-18 2012-01-11 特提斯生物科学公司 糖尿病相关性生物学标记物及其使用方法
WO2010028336A2 (en) * 2008-09-08 2010-03-11 President And Fellows Of Harvard College Fatty acid c16:1n7-palmitoleate a lipokine and biomarker for metabolic status
WO2012040318A2 (en) * 2010-09-23 2012-03-29 University Of Miami Compositions, methods and kits for detecting melanoma and margins of melanoma

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JONES K. L. et al., "Altered lipid metabolism in gastroschisis: A novel hypothesis", AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2013, 161(8), 1860-1865 *
PETER, A. et al., "Hepatic Glucokinase Expression Is Associated With Lipogenesis And Fatty Liver In Humans.", ENDOCRINOLOGY AND METABOLISM, 2011, 96(7), page E1126-E1130 *

Also Published As

Publication number Publication date
JP6557235B2 (ja) 2019-08-07
SG11201604702YA (en) 2016-07-28
WO2015095451A1 (en) 2015-06-25
US20160356798A1 (en) 2016-12-08
CA2933571A1 (en) 2015-06-25
ES2708807T3 (es) 2019-04-11
JP2017500567A (ja) 2017-01-05
AU2014364539A1 (en) 2016-06-16
EP3082833B1 (en) 2018-12-05
EP3082833A1 (en) 2016-10-26
EP3082833A4 (en) 2017-08-09
MX2016008045A (es) 2016-10-12

Similar Documents

Publication Publication Date Title
AU2014364539B2 (en) Biomarkers of de novo lipogenesis and methods using the same" (i.e. change Biomakers to Biomarkers)
EP3321686B1 (en) Biomarkers related to insulin resistance progression and methods using the same
WO2009014639A2 (en) Biomarkers for pre-diabetes, cardiovascular diseases, and other metabolic-syndrome related disorders and methods using the same
JP6158186B2 (ja) インスリン抵抗性に関連するバイオマーカーおよびそれを使用する方法
Steffen et al. Apolipoprotein B is associated with carotid atherosclerosis progression independent of individual cholesterol measures in a 9-year prospective study of Multi-Ethnic Study of Atherosclerosis participants
Gander et al. Metabolic impairment in coronary artery disease: elevated serum acylcarnitines under the spotlights
EP2810079A1 (en) Method for determining liver fat amount and method for diagnosing nafld
Mínguez-Alarcón et al. Pregnancy urinary concentrations of bisphenol A, parabens and other phenols in relation to serum levels of lipid biomarkers: Results from the EARTH study
KR20150107990A (ko) 혈장 대사체를 이용한 고-ldl-콜레스테롤 질환 진단 장치 및 방법
Amirkalali et al. Low serum leptin serves as a biomarker of malnutrition in elderly patients
Kishino et al. Visceral fat thickness in overweight men correlates with alterations in serum fatty acid composition
Schmidt et al. High apoB/apoA-I ratio is associated with increased progression rate of carotid artery intima-media thickness in clinically healthy 58-year-old men: experiences from very long-term follow-up in the AIR study
US20250362315A1 (en) Quantification of lipoprotein subfraction by ion mobility
JP6243413B2 (ja) Ｐｃ−ｏ４２：４−内臓脂肪過多のバイオマーカー
JP6243411B2 (ja) Ｐｃ−ｏ４４：６−内臓脂肪過多のバイオマーカー
Elshorbagy et al. The association of fasting plasma thiol fractions with body fat compartments, biomarker profile, and adipose tissue gene expression
HK1224920A1 (en) Biomarkers of de novo lipogenesis and methods using the same
HK1224920B (en) Biomarkers of de novo lipogenesis and methods using the same
KR20160002495A (ko) 간 효소 및 혈장 대사체를 이용한 심혈관 질환의 예측 또는 진단 방법
Gray et al. Plasma glycosylphosphatidylinositol-specific phospholipase D predicts the change in insulin sensitivity in response to a low-fat but not a low-carbohydrate diet in obese women
Hirayama et al. Fasting serum free glycerol concentration is a potential surrogate marker of visceral obesity and insulin sensitivity in middle-aged Japanese men
Nnamudi et al. Finnish diabetes risk score outperformed triglyceride-glucose index in diabetes risk prediction
Ahmed Assessment of Framingham Risk Score and serum leptin in patients with skin tag
Saha-Roy et al. Serum Ferritin as a Marker of Psychiatric Disorders
Wurst et al. State Markers of Alcohol Use and Their Application

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)